SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mefcom Capital Markets Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531176

INE186C01023

5.3061099

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

63.43

EPS(TTM)

Face Value()

Div & Yield %

Back

Aurobindo Pharma consolidated net profit rises 3.80% in the September 2025 quarter

Nov 06,2025

Net profit of Aurobindo Pharma rose 3.80% to Rs 848.45 crore in the quarter ended September 2025 as against Rs 817.38 crore during the previous quarter ended September 2024. Sales rose 7.73% to Rs 8236.96 crore in the quarter ended September 2025 as against Rs 7646.21 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8236.96	7646.21	8
OPM %	20.37	20.48	-
PBDT	1705.11	1589.74	7
PBT	1275.92	1207.46	6
NP	848.45	817.38	4

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)